Table 3 Activity of fotemustine in relation to group of dose and histotype
Group A, no. pts (%) (histotype) | Group B, no. pts (%) (histotype) | Group C, no. pts (%) (histotype) | |
|---|---|---|---|
Partial Response | 2 (40%) (2 AA) | 4 (26.5%) (1 GBM, 3 AOD) | 2 (10%) (1 AA, 1 AOD) |
Stable Disease | 2 (40%) (1 GBM, 1 AA) | 4 (26.5%) (1 GBM, 2 AA, 1 AOD) | 5 (25%) (2 GBM, 1 AA, 2 AOA) |
Progression | 1 (20%) (1 GBM) | 7 (47%) (2 GBM, 2 AA, 3 AOA) | 13 (65%) (6 GBM, 2 AA, 2 AOA, 3 AOD) |
Total pts | 5 | 15 | 20 |
Total GBM | 2/5 (40%) | 4/15 (26.5%) | 8/20 (40%) |